Navigation Links
WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
Date:3/5/2013

SHANGHAI and PALO ALTO, Calif., March 5, 2013 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, and Open Monoclonal Technology, Inc. (OMT), an innovator in novel transgenic animals for development of human therapeutic antibodies, today announced a second agreement to expand WuXi's use of OMT's OmniRat™ and OmniMouse™ technologies to strengthen the development and commercial opportunities for WuXi's Asian regional and global clients.

The OmniRat platform has now been duplicated at WuXi's Shanghai facility, enabling WuXi to generate antibodies for customers from its own laboratories. WuXi is the first and currently the only company authorized by OMT to host OmniRat in China. This transaction advances WuXi's goal of working with skilled partners to enhance the company's technologies and capabilities to better serve its customers.

Under the new agreement, WuXi's clients can choose to develop and commercialize products globally or regionally in China, Korea, Japan or other Asian territories. Clients that opt for regional rights first can assume global rights prior to the first human dose. This is particularly attractive for companies that have already established regional Asian operations and have aspirations to become global later. OMT retains the global product rights until and unless each option is exercised.

"This new agreement allows WuXi to further expand its service offerings with the OmniRat and OmniMouse platforms," said Edward Hu , Chief Operating Officer and Chief Fin
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
2. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
3. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
4. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
5. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
6. WuXi PharmaTech to Manufacture Ibalizumab for TaiMed Biologics
7. WuXi PharmaTech Receives GLP Certificate from SFDA for Suzhou Toxicology Facility
8. WuXi PharmaTech Announces Second-Quarter 2012 Results
9. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
10. WuXi PharmaTech Announces First-Quarter 2012 Results
11. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Consolidated Net Profit ... Business Highlights   , India Business grew by ... 9.33% to Rs. 4,886.70 Mn Rest of World (ROW) ... Formulations Business grew by 34.53% to Rs. 977.26 Mn ... Glenmark Pharmaceuticals Limited, the research-led global integrated ...
(Date:7/24/2014)... Tenn. , July 24, 2014  In any ... one in 25 patients has at least one hospital-acquired ... Prevention. What,s more, many of these infections prove fatal. ... causing an alarming number of patient deaths per year, ... industry conversation. Consequently, a stronger emphasis ...
(Date:7/24/2014)... 24, 2014 /PRNewswire-iReach/ -- Delivery of the Report ... placed. Photo - http://photos.prnewswire.com/prnh/20140723/129707 ... in-depth market survey on Global and Chinese Hemodialysis ... information of Hemodialysis Machine including its classification, application ... and China,s top manufacturers of Hemodialysis Machine listing ...
Breaking Medicine Technology:Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5
... Simcere Pharmaceutical Group (NYSE: SCR ), a ... marketing of branded generic and proprietary pharmaceuticals in China, ... results for the first quarter ended March 31, 2011 ... in the United States. Simcere,s management will host an ...
... 25, 2011 Leading events organiser UBM Live ... its CPhI, ICSE, P-MEC and BioPh Japan events in Tokyo ... the events have now been rescheduled and will be held ...  The Japanese business community is intent on picking itself up ...
Cached Medicine Technology:Simcere Pharmaceutical Group to Announce First Quarter 2011 Financial Results on Tuesday, May 10, 2011 2Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events 2Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events 3
(Date:7/25/2014)... 25, 2014 Bedros Keuilian has been ... in the country, and is considered the industry’s leading ... on his coaching website, RenegadeMarketing.com, he explains why information ... a good personal trainer. , “I’ve been really privileged ... leaders in the fitness industry and I’ve helped many ...
(Date:7/25/2014)... for Medical Oncology (ESMO), the leading pan-European association ... the proposed EU General Data Protection Regulation [1] ... significant burden to both doctors and cancer patients. ... stipulates ,explicit and specific patient consent, meaning that ... time research is planned in order to consult ...
(Date:7/25/2014)... Seattle, Wa (PRWEB) July 25, 2014 ... More Pdf review recently updated by Vkool.com, ... teach people how to treat some common ...     External hemorrhoids and internal hemorrhoids , ... after pregnancy with hemorrhoids ,     Very ...
(Date:7/25/2014)... As the category creator and world leader in healthy ... transform and improve individual lives worldwide through its exclusive and ... a successful Austin, Texas based "Xocai Activ Drink" author, is ... July to promote the up and coming mxicorp.com/company/igc Eric Worre ... has been a leader in the Network Marketing Profession for ...
(Date:7/24/2014)... York, NY (PRWEB) July 25, 2014 ... innovator in health care quality, has been appointed senior ... effective July 21, 2014. In his new role, he ... initiatives. , Dr. Ting has successfully led quality initiatives ... levels. Nationally, he led teams for the Door-to-Balloon Alliance, ...
Breaking Medicine News(10 mins):Health News:Fitness Marketing Expert Bedros Keuilian’s New Post Shares Why People Still Need Personal Trainers in the Age of Google 2Health News:Fitness Marketing Expert Bedros Keuilian’s New Post Shares Why People Still Need Personal Trainers in the Age of Google 3Health News:Is Europe putting cancer research at risk? 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 2Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 4Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 2Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 3
... little is known about these ,in situ, malignancies, experts say ... women with breast cancer in situ in the United States finds ... that number is expected to increase to more than 1 million. ... newly diagnosed breast cancers. It is the early stage of the ...
... , , , , ... stock will be included in the S&P 500 index following the company,s ... be added to the index on Sept. 1, coinciding with its first ... symbol "CFN." , , "Our inclusion in the ...
... test , TUESDAY, Aug. 25 (HealthDay News) -- In a ... found that saliva contains at least 50 microRNAs that could ... levels in the saliva of 50 people with oral squamous ... 50 microRNAs that may be associated with oral cancer. , ...
... cancer survivors decreases their risk of developing the most ... use is associated with a more than four-fold increased ... in the breast opposite, or contralateral, to the initial ... colleagues at Fred Hutchinson Cancer Research Center were published ...
... progressive resistance training also called strength training ... older adults to improve their health. A Virginia Tech ... physiology, and medicine is designing a program to help ... in order to prevent diabetes. "Much attention ...
... Aug. 25 One month ago, July 20, 2009, ... through all 48 states in the continental U.S. in 48 days, a total ... Nagle now has passed well beyond the halfway point on his route, bicycling ... In addition to eyeing a Guinness World Record with his ride, Nagle ...
Cached Medicine News:Health News:More Women Surviving After Early Breast Cancer 2Health News:More Women Surviving After Early Breast Cancer 3Health News:CareFusion Corp to be Included in S&P 500 Index 2Health News:Saliva May Help Spot Oral Cancer Early 2Health News:Long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer 2Health News:Researchers evaluate resistance training for diabetes prevention 2Health News:Researchers evaluate resistance training for diabetes prevention 3Health News:College Student's '48 States in 48 Days' Bike Ride Moves Well Beyond the Halfway Point 2
Quatroloc Revision Hip System...
Severe revision options for the knee and hip...
The Precedent establishes a new generation of revision hip stems....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: